share_log

Earnings Preview: Syra Health

Earnings Preview: Syra Health

收益預覽:Syra Health
Benzinga ·  10/29 05:01

Syra Health (NASDAQ:SYRA) is set to give its latest quarterly earnings report on Tuesday, 2024-10-29. Here's what investors need to know before the announcement.

Syra Health(納斯達克:SYRA)將於2024年10月29日星期二發佈其最新季度業績。投資者在公告之前需要了解以下內容。

Analysts estimate that Syra Health will report an earnings per share (EPS) of $-0.21.

分析師估計Syra Health的每股收益(EPS)爲-0.21美元。

The market awaits Syra Health's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

市場熱切期待Syra Health的公告,希望能超過預期,併爲下個季度提供積極的指引。

It's important for new investors to understand that guidance can be a significant driver of stock prices.

新投資者需要明白,指引對股價有重要影響。

Overview of Past Earnings

過去收益的概述

During the last quarter, the company reported an EPS missed by $0.02, leading to a 0.61% increase in the share price on the subsequent day.

在上一季度,公司報告的每股收益低於0.02美元,導致隨後一天股價上漲了0.61%。

Here's a look at Syra Health's past performance and the resulting price change:

讓我們回顧一下Syra Health的過往表現以及由此產生的價格變動:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -0.19 -0.19 -0.09
EPS Actual -0.21 -0.22 -0.16 -0.08
Price Change % 1.0% -5.0% -15.0% 14.000000000000002%
季度 2024年第二季度 Q1 2024 2023年第四季度 2023年第三季度
每股收益預估值 -0.19 -0.19 -0.09
每股收益實際值 -0.21 -0.22 -0.16 -0.08
價格變更% 1.0% -5.0% -15.0% 14.000000000000002%

Stock Performance

股票表現

Shares of Syra Health were trading at $0.404 as of October 25. Over the last 52-week period, shares are down 67.62%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

截至10月25日,Syra Health的股價爲0.404美元。在過去52周內,股價下跌了67.62%。鑑於這些回報通常是負面的,長期股東可能在這次業績發佈前感到不滿。

To track all earnings releases for Syra Health visit their earnings calendar on our site.

要查看Syra Health所有業績發佈情況,請訪問我們網站上的業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動化內容引擎生成並由編輯審查。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論